Investigation of the intra-tumoural concentration and activity of sorafenib in cutaneous schwannomas.

Trial Profile

Investigation of the intra-tumoural concentration and activity of sorafenib in cutaneous schwannomas.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Sorafenib (Primary)
  • Indications Nerve sheath neoplasms
  • Focus Pharmacokinetics
  • Most Recent Events

    • 27 Feb 2016 Status changed from recruiting to completed as per ISRCTN: Current Controlled Trials record.
    • 28 Jan 2016 Planned End Date changed from 31 Dec 2015 to 31 Dec 2016, as reported by United Kingdom Clinical Research Network record
    • 21 Aug 2014 Planned End Date changed from 31 Jul 2014 to 31 Jul 2015 according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top